Theres is an immunologist with 20 years of experience in industry and academia across a variety of fields, including cell therapy, oncology, and allergies.

Prior to joining Epitopea, Theres held the position of Head of Translational Science – Product Characterisation at Achilles Therapeutics. Under her leadership the Product Characterisation team ran a wide range of immunological assays to characterize phenotypic and functional properties of First in Human autologous T cell products. As one of the first members of Achilles Therapeutics, she played an integral part in developing autologous T cell therapies targeting clonal neo-antigen specific cancer mutations.

Prior to joining Achilles, Theres spent over 10 years at the Department of Immunology at UCL, where her studies focused on understanding the T cell receptor repertoire in a variety of diseases.

Theres holds a PhD in Immunology from University College London (UCL).